- Home
- TMO
as 04-18-2025 1:44pm EST
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
Upcoming Earnings Alert:
Get ready for potential market movements as Thermo Fisher Scientific Inc TMO prepares to release earnings report on 23 Apr 2025.
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 203.5B | IPO Year: | N/A |
| Target Price: | $640.95 | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 16.53 | EPS Growth: | 6.99 |
| 52 Week Low/High: | $409.85 - $627.88 | Next Earning Date: | 04-23-2025 |
| Revenue: | $42,879,000,000 | Revenue Growth: | 0.05% |
| Revenue Growth (this year): | 3.34% | Revenue Growth (next year): | 6.58% |
Latest Thermo Fisher Scientific Inc News
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Thermo Fisher Scientific Inc. (TMO): Among the Innovative Healthcare Stocks to Watch in 2025
MT Newswires
2 days ago
Leerink Adjusts Price Target on Thermo Fisher Scientific to $625 From $640, Maintains Outperform Rating
MT Newswires
2 days ago
Wells Fargo Adjusts Price Target on Thermo Fisher Scientific to $580 From $680, Maintains Overweight Rating
Zacks
2 days ago
Stay Ahead of the Game With Thermo Fisher (TMO) Q1 Earnings: Wall Street's Insights on Key Metrics
MT Newswires
3 days ago
Bernstein Cuts Price Target on Thermo Fisher Scientific to $585 From $690, Keeps Outperform Rating
MT Newswires
3 days ago
Baird Cuts Price Target on Thermo Fisher Scientific to $603 From $660, Keeps Outperform Rating
Zacks
3 days ago
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for
Zacks
3 days ago
Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings
Compare TMO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.